Company news

AptarGroup, Inc. news in 2025

AptarGroup, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)

December 17, 2025

Aptar Named One of America’s Most Responsible Companies by Newsweek for the Seventh Consecutive Year

December 4, 2025

Aptar Acquires Sommaplast, a Specialized Provider of Oral Dosing Pharma Packaging Solutions

December 1, 2025

Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025

November 11, 2025

Aptar Reports Third Quarter 2025 Results

October 30, 2025

Aptar Digital Health Announces FDA 510(k) Clearance for HeroTracker® Sense, a Connected Add-On Device for Metered-Dose Inhalers

October 16, 2025

Aptar Named Among Top 100 of the ‘World’s Top Companies for Women 2025’ by Forbes

October 15, 2025

Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength

September 8, 2025

Aptar Announces 2025 Investor Day

September 4, 2025

Aptar Reports Second Quarter 2025 Results

July 31, 2025

Aptar Declares Quarterly Dividend

July 10, 2025

Aptar Named One of the World’s Most Sustainable Companies by TIME for Second Consecutive Year

June 25, 2025

Aptar to Participate in Upcoming Investor Conferences

June 2, 2025

Aptar Releases 2024 Corporate Sustainability Report

May 29, 2025

Aptar Reports First Quarter 2025 Results

May 1, 2025

Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers

April 16, 2025

Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year

April 15, 2025

Aptar Named One of Barron’s 100 Most Sustainable U.S. Companies for the Seventh Consecutive Year

March 27, 2025

Aptar Recognized with Prestigious 'A' Score on the CDP Climate Change Assessment

March 20, 2025

Calls in 2025

Decks in 2025